Literature DB >> 8286349

Role of the amino-terminal domain in regulating interactions of annexin I with membranes: effects of amino-terminal truncation and mutagenesis of the phosphorylation sites.

W Wang1, C E Creutz.   

Abstract

Phosphorylation of the N-terminal tail by protein kinase C strongly inhibits the ability of bovine or human annexin I to aggregate chromaffin granules by increasing the calcium requirement 4-fold (Wang, W., & Creutz, C. E. (1992) Biochemistry 31, 9934-9936). In the present study three forms of human annexin I truncated in the amino terminus at residue Trp-12, Lys-26, or Lys-29 exhibit dramatic differences in their sensitivities to calcium in a chromaffin granule aggregation assay, while the [Ca2+](1/2)max values for binding of the truncated proteins to granule membranes are similar. Cleavage at Trp-12 causes a 3-fold decrease in calcium sensitivity in the membrane aggregation assay, while cleavage at Lys-26 causes a 4-fold enhancement of calcium sensitivity. In contrast, cleavage at Lys-29 results in virtually no change in calcium sensitivity. Mutagenic substitution with negatively charged amino acids of Ser-27, a site for phosphorylation by protein kinase C, or Tyr-21, a site for phosphorylation by the epidermal growth factor receptor kinase, mimics the inhibition of granule-aggregating activity seen with phosphorylation by protein kinase C. When bovine chromaffin cells are stimulated to secrete by nicotine, annexin I is phosphorylated in the amino terminus. Thr-24 and Ser-28, which are sites for phosphorylation by protein kinase C in vitro, are two of the sites phosphorylated in vivo in stimulated chromaffin cells. These data demonstrate that the ability of annexin I to promote membrane aggregation is highly sensitive to changes in the structure of the N-terminal domain of the protein.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8286349     DOI: 10.1021/bi00167a036

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Evidence for specific annexin I-binding proteins on human monocytes.

Authors:  N J Goulding; L Pan; K Wardwell; V C Guyre; P M Guyre
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

2.  Annexins I and II bind to lipid A: a possible role in the inhibition of endotoxins.

Authors:  D A Eberhard; S R Vandenberg
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  The association of annexin I with early endosomes is regulated by Ca2+ and requires an intact N-terminal domain.

Authors:  J Seemann; K Weber; M Osborn; R G Parton; V Gerke
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

4.  Structural requirements for annexin I-S100C complex-formation.

Authors:  J Seemann; K Weber; V Gerke
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

5.  In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors.

Authors:  Phil Oh; Jacqueline E Testa; Per Borgstrom; Halina Witkiewicz; Yan Li; Jan E Schnitzer
Journal:  Nat Med       Date:  2014-08-17       Impact factor: 53.440

Review 6.  Plasma Membrane Repair in Health and Disease.

Authors:  Alexis R Demonbreun; Elizabeth M McNally
Journal:  Curr Top Membr       Date:  2015-11-27       Impact factor: 3.049

7.  Binding to phosphatidyl serine membranes causes a conformational change in the concave face of annexin I.

Authors:  M de la Fuente; C G Ossa
Journal:  Biophys J       Date:  1997-01       Impact factor: 4.033

8.  Significance of Polar Charged Amino Acids in Compound Mutations in EGFR-mutated Patients Treated With First-line Afatinib.

Authors:  Hiroaki Satoh; Yuika Sasatani; Kunihiko Miyazaki; Yoshiharu Sato; Nobuyuki Hizawa
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

9.  FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication.

Authors:  XuSheng Ma; KeShan Zhang; ZhiKuan Luo; XiaoFeng Nian; S K Mohiuddin Choudhury; ZiXiang Zhu; Rui Song; JingJing Pei; YanLi Huo; YuanYuan Li; Fan Yang; WeiJun Cao; HuiSheng Liu; XiangTao Liu; HaiXue Zheng
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

Review 10.  Overcoming key biological barriers to cancer drug delivery and efficacy.

Authors:  Susy M Kim; Peggy H Faix; Jan E Schnitzer
Journal:  J Control Release       Date:  2017-09-14       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.